Osteoclast‐Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss

Sacha Flammier, Olivier Peyruchaud, Fanny Bourguillault, F. Duboeuf, J. Davignon, Derek D. Norman, Sylvie Isaac, Hubert Marotte, Gábor Tigyi, Irma Machuca‐Gayet,

Arthritis & Rheumatology · 2019 · 21 citations · 38 references

DOIFull text

Open access

Abstract

Our results identify ATX as a novel OC factor that specifically controls inflammation-induced bone erosions and systemic bone loss. Therefore, ATX inhibition offers a novel therapeutic approach for potentially preventing bone erosion in patients with RA.

References

38